Download Free Sample Report

RNA Next-Generation Sequencing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global RNA Next-Generation Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the RNA Next-Generation Sequencing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

• Enrichment Approaches
• Amplicon-Based Approaches

Segment by Application

• Research Institutes
• Hospitals and Clinics
• Biotechnology Company
• Diagnostic Lab

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• U.A.E

By Company

• Roche
• Illumina
• Thermo Fisher Scientific
• Beckman Coulter
• Abbott Molecular
• Pacific Biosciences
• Oxford Nanopore Technologies
• Eurofins Scientific
• Macrogen
• GENEWIZ
• BGI
• Berry Genomics
• QIAGEN